Skip to main content
. 2020 Jan 9;7(1):25–35. doi: 10.1002/ehf2.12567

Figure 3.

Figure 3

Target dose. ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor neprilysin inhibitor; MRA, mineralocorticoid receptor antagonist.